TransMedics Group Inc.
TMDX | NASDAQ
$87.29
+$0.87 (+1.01%)
At close: Sep 21, 2026, 4:00 PM ET
$88.03
+$0.74 (+0.85%)
Pre-market:
Sep 22, 2026, 6:18 AM ET
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 | FY 2020 Dec 30, 2020 |
|---|---|---|---|---|---|---|
PE Ratio | 21.72 | 58.27 | -102.51 | -50.18 | -11.97 | -17.16 |
PEG Ratio | 0.05 | -0.24 | 2.74 | 2.17 | -0.32 | 0.34 |
PS Ratio | 6.83 | 4.69 | 10.62 | 19.52 | 17.49 | 19.17 |
PB Ratio | 8.74 | 9.06 | 18.71 | 9.74 | 7.80 | 4.73 |
P/FCF Ratio | 30.96 | -25.60 | -13.36 | -31.60 | -16.34 | -16 |
P/OCF Ratio | 21.44 | 42.45 | -197.01 | -39.82 | -18.33 | -16.24 |
OCF/S Ratio | 31.85 | 11.05 | -5.39 | -49.02 | -95.38 | -118.04 |
Debt / Equity Ratio | 0.99 | 2.27 | 3.76 | 0.36 | 0.65 | 0.33 |
Quick Ratio | 6.59 | 7.52 | 8.49 | 9.79 | 4.47 | 11.35 |
Current Ratio | 7.14 | 8.30 | 9.30 | 10.66 | 5.11 | 12.36 |
Asset Turnover | 0.57 | 0.55 | 0.34 | 0.34 | 0.22 | 0.17 |
Interest Coverage | 7.88 | 2.60 | -2.66 | -8.44 | -10.18 | -6.62 |
Return on Equity | 40.22% | 15.51% | -18.24% | -19.34% | -65.16% | -27.67% |
Return on Assets | 17.81% | 4.41% | -3.54% | -13.07% | -32.78% | -18.91% |
Return on Invested Capital | 10.94% | 4.98% | -4.13% | -12.33% | -35.31% | -18.83% |
Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
FCF Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | 59.92% | 59.36% | 63.77% | 69.84% | 69.92% | 64.88% |
Net Profit Margin | 31.43% | 8.03% | -10.36% | -38.77% | -146.11% | -112.13% |
Pretax Profit Margin | 17.76% | 8.10% | -11.04% | -38.70% | -145.99% | -112% |
Operating Profit Margin | 17.93% | 8.49% | -11.89% | -33.64% | -130.29% | -102.91% |
FCF Margin | 22.06% | -18.33% | -79.50% | -61.76% | -107.01% | -119.82% |
EBITDA Margin | 24.52% | 15.84% | -3.19% | -30.99% | -127.18% | -90.31% |
Add to Watchlist
Select watchlists to add or remove TMDX